This inventor holds 3 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Stoke Therapeutics, Inc.. Active years: 2020-2024.
Company Filing History:
Years Active: 2020-2024
Title: Innovations by Inventor Zhou Han
Introduction
Zhou Han is an accomplished inventor based in Natick, MA (US). He has made significant contributions to the field of therapeutic agents, particularly in relation to genetic conditions. With a total of 3 patents, his work focuses on addressing critical health issues through innovative solutions.
Latest Patents
Zhou Han's latest patents include groundbreaking research on antisense oligomers for the treatment of conditions and diseases. His work highlights how alternative splicing events in the SCN1A gene can lead to non-productive mRNA transcripts, resulting in aberrant protein expression. Therapeutic agents that target these alternative splicing events can modulate the expression levels of functional proteins in patients with Dravet Syndrome. These agents aim to inhibit aberrant protein expression and can be utilized to treat conditions caused by deficiencies in SCN1A, SCN8A, or SCN5A proteins.
Career Highlights
Zhou Han is currently employed at Stoke Therapeutics, Inc., where he continues to advance his research and development efforts. His innovative approach to genetic therapies has positioned him as a key player in the field.
Collaborations
Zhou collaborates with Isabel Aznarez, working together to push the boundaries of therapeutic innovations.
Conclusion
Zhou Han's contributions to the field of genetic therapies through his patents and collaborations demonstrate his commitment to improving health outcomes for patients. His work is paving the way for future advancements in the treatment of genetic conditions.